Shares of IDEX Corporation (NYSE:IEX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine analysts that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $226.80.
Several research firms recently weighed in on IEX. Citigroup lifted their price objective on shares of IDEX from $202.00 to $243.00 and gave the stock a "buy" rating in a research report on Thursday, February 5th. Argus raised shares of IDEX from a "hold" rating to a "buy" rating and set a $240.00 price objective on the stock in a research report on Friday, February 6th. Royal Bank Of Canada boosted their price target on shares of IDEX from $211.00 to $244.00 and gave the company an "outperform" rating in a research report on Thursday, February 5th. Robert W. Baird set a $247.00 price target on shares of IDEX in a research report on Thursday, February 5th. Finally, Oppenheimer reissued an "outperform" rating and issued a $230.00 price target on shares of IDEX in a research report on Thursday, February 5th.
Read Our Latest Research Report on IEX
IDEX Stock Up 2.0%
Shares of NYSE IEX opened at $205.03 on Tuesday. The stock has a market capitalization of $15.24 billion, a P/E ratio of 31.99, a P/E/G ratio of 2.03 and a beta of 0.99. The company has a 50-day moving average price of $199.81 and a 200-day moving average price of $184.23. IDEX has a 1 year low of $157.25 and a 1 year high of $217.15. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.86 and a quick ratio of 2.02.
IDEX (NYSE:IEX - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The industrial products company reported $2.10 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.06. IDEX had a net margin of 13.98% and a return on equity of 15.03%. The business had revenue of $899.10 million for the quarter, compared to analysts' expectations of $882.00 million. During the same period in the previous year, the company earned $2.04 earnings per share. The firm's revenue for the quarter was up 4.2% compared to the same quarter last year. IDEX has set its Q1 2026 guidance at 1.730-1.780 EPS and its FY 2026 guidance at 8.150-8.35 EPS. On average, equities research analysts forecast that IDEX will post 8.26 EPS for the current fiscal year.
Hedge Funds Weigh In On IDEX
Hedge funds and other institutional investors have recently bought and sold shares of the stock. GoalVest Advisory LLC bought a new stake in shares of IDEX in the 4th quarter worth approximately $26,000. Laurel Wealth Advisors LLC bought a new position in IDEX in the 4th quarter worth $27,000. Capital A Wealth Management LLC bought a new position in IDEX in the 2nd quarter worth $28,000. UMB Bank n.a. raised its holdings in IDEX by 61.0% in the 3rd quarter. UMB Bank n.a. now owns 198 shares of the industrial products company's stock worth $32,000 after purchasing an additional 75 shares in the last quarter. Finally, Cromwell Holdings LLC grew its position in shares of IDEX by 41.1% in the 4th quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company's stock worth $35,000 after buying an additional 58 shares during the period. Hedge funds and other institutional investors own 97.96% of the company's stock.
About IDEX
(
Get Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company's core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.